Cargando…
Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543075/ https://www.ncbi.nlm.nih.gov/pubmed/35491519 http://dx.doi.org/10.1111/dom.14740 |
| _version_ | 1784804291740958720 |
|---|---|
| author | Spiliotis, Ioannis I. Chalk, Rod Gough, Stephen Rorsman, Patrik |
| author_facet | Spiliotis, Ioannis I. Chalk, Rod Gough, Stephen Rorsman, Patrik |
| author_sort | Spiliotis, Ioannis I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9543075 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Blackwell Publishing Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95430752022-10-14 Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study Spiliotis, Ioannis I. Chalk, Rod Gough, Stephen Rorsman, Patrik Diabetes Obes Metab Research Letters Blackwell Publishing Ltd 2022-05-18 2022-08 /pmc/articles/PMC9543075/ /pubmed/35491519 http://dx.doi.org/10.1111/dom.14740 Text en © 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Research Letters Spiliotis, Ioannis I. Chalk, Rod Gough, Stephen Rorsman, Patrik Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title | Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title_full | Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title_fullStr | Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title_full_unstemmed | Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title_short | Reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: Results of the LEGEND‐A pilot study |
| title_sort | reducing hyperglucagonaemia in type 2 diabetes using low‐dose glibenclamide: results of the legend‐a pilot study |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543075/ https://www.ncbi.nlm.nih.gov/pubmed/35491519 http://dx.doi.org/10.1111/dom.14740 |
| work_keys_str_mv | AT spiliotisioannisi reducinghyperglucagonaemiaintype2diabetesusinglowdoseglibenclamideresultsofthelegendapilotstudy AT chalkrod reducinghyperglucagonaemiaintype2diabetesusinglowdoseglibenclamideresultsofthelegendapilotstudy AT goughstephen reducinghyperglucagonaemiaintype2diabetesusinglowdoseglibenclamideresultsofthelegendapilotstudy AT rorsmanpatrik reducinghyperglucagonaemiaintype2diabetesusinglowdoseglibenclamideresultsofthelegendapilotstudy |